S&S Healthcare Holding Ltd., together with its subsidiaries, primarily focuses on the research and development, manufacture, and sale of medical imaging devices in the United States, Europe, Asia, and internationally.
Price History & Performance
|Historical stock prices|
|Current Share Price||NT$6.25|
|52 Week High||NT$5.40|
|52 Week Low||NT$17.40|
|1 Month Change||-3.55%|
|3 Month Change||2.80%|
|1 Year Change||-60.57%|
|3 Year Change||-51.17%|
|5 Year Change||-90.53%|
|Change since IPO||-96.99%|
Recent News & Updates
Here's Why S&S Healthcare Holding (GTSM:4198) Can Afford Some Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
Is S&S Healthcare Holding (GTSM:4198) A Risky Investment?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
|4198||TW Medical Equipment||TW Market|
Return vs Industry: 4198 underperformed the TW Medical Equipment industry which returned 6.5% over the past year.
Return vs Market: 4198 underperformed the TW Market which returned 36.1% over the past year.
Stable Share Price: 4198 is more volatile than 75% of TW stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: 4198's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of TW stocks.
About the Company
S&S Healthcare Holding Ltd., together with its subsidiaries, primarily focuses on the research and development, manufacture, and sale of medical imaging devices in the United States, Europe, Asia, and internationally. It also develops digital diagnostic X-ray systems; and researches, develops, and produces bone densitometry and body composition assessment products. The company was formerly known as Swissray Global Healthcare Holding Ltd.
Is S&S Healthcare Holding undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate 4198's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate 4198's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: 4198 is unprofitable, so we can't compare its PE Ratio to the TW Medical Equipment industry average.
PE vs Market: 4198 is unprofitable, so we can't compare its PE Ratio to the TW market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 4198's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 4198 is overvalued based on its PB Ratio (4.8x) compared to the TW Medical Equipment industry average (2.1x).
How is S&S Healthcare Holding forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as S&S Healthcare Holding has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has S&S Healthcare Holding performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 4198 is currently unprofitable.
Growing Profit Margin: 4198 is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: 4198 is unprofitable, but has reduced losses over the past 5 years at a rate of 35.2% per year.
Accelerating Growth: Unable to compare 4198's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 4198 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (9.5%).
Return on Equity
High ROE: 4198 has a negative Return on Equity (-85.99%), as it is currently unprofitable.
How is S&S Healthcare Holding's financial position?
Financial Position Analysis
Short Term Liabilities: 4198's short term assets (NT$226.8M) exceed its short term liabilities (NT$82.8M).
Long Term Liabilities: 4198's short term assets (NT$226.8M) exceed its long term liabilities (NT$121.9M).
Debt to Equity History and Analysis
Debt Level: 4198's debt to equity ratio (113.9%) is considered high.
Reducing Debt: 4198's debt to equity ratio has increased from 12.6% to 113.9% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 4198 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 4198 has sufficient cash runway for 2 years if free cash flow continues to grow at historical rates of 36.5% each year.
What is S&S Healthcare Holding current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 4198's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 4198's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 4198's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 4198's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 4198's dividend in 3 years as they are not forecast to pay a notable one for the TW market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
S&S Healthcare Holding has no CEO, or we have no data on them.
Experienced Management: 4198's management team is considered experienced (3.1 years average tenure).
Experienced Board: 4198's board of directors are considered experienced (5.2 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 22.9%.
S&S Healthcare Holding Ltd.'s employee growth, exchange listings and data sources
- Name: S&S Healthcare Holding Ltd.
- Ticker: 4198
- Exchange: TPEX
- Founded: 1988
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: NT$503.375m
- Shares outstanding: 80.54m
- Website: https://www.swissray.com
- S&S Healthcare Holding Ltd.
- No. 85 Xinhu 1st Road
- 7th Floor
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/22 15:23|
|End of Day Share Price||2021/09/22 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.